Report of Foreign Issuer (6-k)
December 11 2018 - 8:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December, 2018
Commission File Number: 001-36582
Auris Medical Holding AG
(Exact name of registrant as specified
in its charter)
Bahnhofstrasse 21
6300 Zug, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
On December 11, 2018, Auris Medical Holding AG (the “Company”
or “we”) entered into a purchase agreement (the “
Purchase Agreement
”) with FiveT Capital AG (“
FTC
”),
pursuant to which FTC committed to subscribe for 1,700,000 of our common shares for an aggregate price of $707,200, subject to
certain limitations and conditions set forth in the Purchase Agreement and pursuant to our effective shelf registration statement
on Form F-3 (Registration No. 333-228121), filed with the Securities and Exchange Commission (the “
SEC
”) in
accordance with the provisions of the Securities Act of 1933, as amended (the “
Securities Act
”), which was declared
effective on November 14, 2018 and the related prospectus supplement dated December 11, 2018.
The Purchase Agreement contains customary representations, warranties
and agreements of the parties, indemnification rights of FTC and other obligations of the parties.
INCORPORATION BY REFERENCE
This Report on Form 6-K shall be deemed to be incorporated by
reference into the registration statement on Form F-3 (Registration Number 333-228121) and the registration statement on Form S-8
(Registration Number 333-223855) of Auris Medical Holding AG and to be a part thereof from the date on which this report is filed,
to the extent not superseded by documents or reports subsequently filed or furnished.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
Auris Medical Holding AG
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Hernan Levett
|
|
|
|
|
|
Name:
|
Hernan Levett
|
|
|
|
|
|
Title:
|
Chief Financial Officer
|
|
Date: December 11, 2018
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Apr 2023 to Apr 2024